ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

CCCC C4 Therapeutics Inc

6.16
-0.64 (-9.41%)
2024年5月11日 - 終了
15分遅延
名称 銘柄コード 市場 種別
C4 Therapeutics Inc CCCC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.64 -9.41% 6.16 09:00:00
始値 安値 高値 終値 前日終値
6.85 6.15 6.935 6.16 6.80
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0820:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0820:07EDGAR2Form 8-K - Current report
2024/5/0820:00GLOBEC4 Therapeutics Reports First Quarter 2024 Financial Results..
2024/4/3005:01GLOBEC4 Therapeutics Announces Inducement Grant Under Nasdaq..
2024/4/0920:00GLOBEC4 Therapeutics to Participate in the Stifel 2024 Targeted..
2024/4/0821:00GLOBEC4 Therapeutics Presents New Preclinical Data for CFT1946..
2024/3/0909:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0909:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0909:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0909:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0909:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:10EDGAR2Form 8-K - Current report
2024/3/0606:30GLOBEC4 Therapeutics to Present New Preclinical Data on Highly..
2024/3/0421:05EDGAR2Form 8-K - Current report
2024/3/0421:00GLOBEC4 Therapeutics Announces Strategic Discovery Research..
2024/2/2223:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2221:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2221:15EDGAR2Form 8-K - Current report
2024/2/2221:00GLOBEC4 Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/2/1607:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1607:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1607:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1607:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1607:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1423:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0600:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0223:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1306:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/1121:05EDGAR2Form 8-K - Current report
2024/1/1006:06EDGAR2Form 8-K - Current report
2024/1/1006:01GLOBEC4 Therapeutics Announces 2024 Priorities and Extended Cash..
2024/1/0506:01GLOBEC4 Therapeutics Announces Closing of $25 Million Equity..
2024/1/0421:00GLOBEC4 Therapeutics to Present at the 42nd Annual J.P. Morgan..
2024/1/0406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2306:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/1306:28EDGAR2Form 8-K - Current report
2023/12/1306:01GLOBEC4 Therapeutics Announces Positive Data from CFT7455 Phase 1..
2023/12/1223:15APSBiotech Catches Major Premarket Bid
2023/12/1221:15EDGAR2Form 8-K - Current report
2023/12/1221:00GLOBEC4 Therapeutics Announces License and Research Collaboration..
2023/11/2821:00GLOBEC4 Therapeutics to Host Webcast to Present New Dose..
2023/11/2021:05EDGAR2Form 8-K - Current report
2023/11/2021:00GLOBEC4 Therapeutics Strengthens Board of Directors with Owen..
2023/11/1406:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/0120:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0120:18EDGAR2Form 8-K - Current report
2023/11/0120:00GLOBEC4 Therapeutics Reports Third Quarter 2023 Financial Results..
2023/10/1120:00GLOBEC4 Therapeutics Announces Upcoming Data Presentations for..
2023/10/0405:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock